Social Media Ideas for Bioa

BioAge Labs, Inc. (BIOA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

bioAffinity Technologies, Inc. (BIAF) Discusses Noninvasive Testing and Risk Stratification for Indeterminate Lung Nodul...

Cytomos’ AuraCyt Digital Predictive Cell Analytics Platform Showcased at BIO Conference

Cytomos says its benchtop cell analytics intelligence system combines the compact Celledonia analyzer with the sensors of the AuraCyt modules to transform complex cellular data int...

Jade Biosciences, Inc. (JBIO) Discusses Positive Interim Results From JADE101 Phase I Healthy Volunteer Study and Develo...

Absci Corporation: A Big Binary Approaching In Alopecia

ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout

AAIC: Biogen bolsters hopes for Alzheimer's pivotal push as anti-tau oligo slows cognitive decline

Biogen's leading tau-targeting candidate has slowed cognitive decline across a suite of different clinical assessments, backing up the pharma’s decision to race the molecule into p...

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

SHENZHEN, China, July 5, 2026 /PRNewswire/ -- MGI's subsidiary, Genoria AI, in collaboration with the Shanghai Artificial Intelligence Laboratory, today announced the launch of two...

BridgeBio: "Strong Buy" Attruby Differentiation And Several NDA Submissions In Play

BioMarin Pharmaceutical

BioMarin Pharmaceutical Anonymous (not verified) Fri, 06/12/2026 - 17:51 field_thread_url https://cafepharma.com/boards/threads/biomarin-pharmaceutical.710...

BioMarin Pharmaceutical

BioMarin Pharmaceutical Anonymous (not verified) Mon, 06/22/2026 - 00:00 field_thread_url https://cafepharma.com/boards/threads/biomarin-pharmaceutical.710...

BridgeBio

BridgeBio Anonymous (not verified) Thu, 07/09/2026 - 09:10 field_thread_url https://cafepharma.com/boards/threads/bridgebio.698762/ boar...

Major Biopharmaceutical Company Files First-in-Human Trial Supported by PAK BioSolutions GMP Purification System

A major biopharmaceutical company has filed a First-in-Human (FIH) clinical trial application with drug product manufactured using the PAK BioSolutions system. The milestone demons...

BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows

BMS is the latest large pharma company to make a major bet on AI, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared intelligence platform”...

How iBio aims to stand out in obesity by targeting ‘both sides of the equation’ for antibody discovery

Upon finally reaching the clinic, iBio feels vindicated about the artificial intelligence-powered discovery platform it picked up in 2022.

<![CDATA[The Only AI Simulation Built for Life Sciences ]]>

BCI Launches B-Kool®, a Plant-Based Technology that Prevents Bacterial Contamination without Biocides 

B-Kool technology derived from BCI’s patented biostealth platform brings more than a  decade of medical device innovation to textiles, consumer products, and industrial  materials ...

Parse Biosciences and bit.bio Announce Landmark Alliance

This Parse Biosciences and bit.bio alliance combines single-cell RNA sequencing and causal transcriptomics to map transcription factor-driven cell identity, enabling improved disea...

Ipca inks licensing agreement with Bhami Research for biologics delivery platform access

Licencing agreement grants Ipca access to Bhami Research’s proprietary high-concentration subcutaneous biologics delivery platform for the development and commercialisation of mult...

Boehringer Ingelheim Launches Discovery Collaboration with Immunai to Identify Novel T-Cell Targets Across Oncology and...

Immunai, a leading AI biotech company specialized in mapping the human immune system, today announced a multi-project collaboration and an initial discovery program with Boehringe...

WuXi AppTec’s 1260H Listing Brings the BIOSECURE Act Back to Center Stage

By Steven J. Gonzalez —

BIC broadly welcomes the fundamental direction of the Industrial Accelerator Act and flags the gaps in some key operatio...

The Bio-based Industries provided its response to the European Commission's Call for Feedback on the proposed Regulation on the EU Industrial Accelerator Act (IAA), aiming to str...

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Bi...

BioRestorative Therapies, Inc. today announced the successful completion of manufacturing for its BRTX-100 Phase 2 clinical trial.

Beigene

Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...